Results 121 to 130 of about 7,055,245 (153)

Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use Among Outpatients Diagnosed With COVID-19. [PDF]

Am J Cardiol, 2020
Bae DJ, Tehrani DM, Rabadia SV, Frost M, Parikh RV, Calfon-Press M, Aksoy O, Umar S, Ardehali R, Rabbani A, Bokhoor P, Nsair A, Currier J, Tobis J, Fonarow GC, Dave R, Rafique AM.   +16 more
europepmc   +1 more source

Erratum to renal progenitor cells modulated by angiotensin II receptor blocker (ARB) medication and differentiation towards podocytes in anti-thy1.1 nephritis. [PDF]

Ann Transl Med, 2020
Wu D, Bai J, Cui S, Fu B, Yin Z, Cai G, Chen X.   +6 more
europepmc   +1 more source

Correction to: Angiotensin II receptor blocker LCZ696 attenuates cardiac remodeling through the inhibition of the ERK signaling pathway in mice with pregnancy‑associated cardiomyopathy. [PDF]

Cell Biosci, 2020
Wang Y, Guo Z, Gao Y, Liang P, Shan Y, He J.   +5 more
europepmc   +1 more source

Continued In-Hospital Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use in Hypertensive COVID-19 Patients Is Associated With Positive Clinical Outcome. [PDF]

J Infect Dis, 2020
Lam KW, Chow KW, Vo J, Hou W, Li H, Richman PS, Mallipattu SK, Skopicki HA, Singer AJ, Duong TQ.   +9 more
europepmc   +1 more source

Effects of angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker on one-year outcomes of patients with atrial fibrillation: insights from a multicenter registry study in China. [PDF]

J Geriatr Cardiol, 2020
Lyu SQ, Yang YM, Zhu J, Wang J, Wu S, Ren JM, Zhang H, Shao XH.   +7 more
europepmc   +1 more source

Angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker treatment and haemodynamic factors are associated with increased cardiac mRNA expression of angiotensin-converting enzyme 2 in patients with cardiovascular disease. [PDF]

Eur J Heart Fail, 2020
Lebek S, Tafelmeier M, Messmann R, Provaznik Z, Schmid C, Maier LS, Birner C, Arzt M, Wagner S.   +8 more
europepmc   +1 more source

Olmesartan Medoxomil, An Angiotensin II-Receptor Blocker, Ameliorates Renal Injury In db/db Mice. [PDF]

Drug Des Devel Ther, 2019
Zhu Y, Li ZL, Ding A, Yang H, Zhu WP, Cui TX, Zhang HT, Zhang H.   +7 more
europepmc   +1 more source

Associations Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blocker Use, Gastrointestinal Symptoms, and Mortality Among Patients With COVID-19. [PDF]

Gastroenterology, 2020
Tan ND, Qiu Y, Xing XB, Ghosh S, Chen MH, Mao R.   +5 more
europepmc   +1 more source

Angiotensin II receptor blocker attenuates stress pressor response in young adult African Americans. [PDF]

J Clin Hypertens (Greenwich), 2019
Jeong JH, Hanevold C, Harris RA, Kapuku G, Pollock J, Pollock D, Harshfield G.   +6 more
europepmc   +1 more source

Renal progenitor cells modulated by angiotensin II receptor blocker (ARB) medication and differentiation towards podocytes in anti-thy1.1 nephritis. [PDF]

Ann Transl Med, 2020
Wu D, Bai J, Cui S, Fu B, Yin Z, Cai G, Chen X.   +6 more
europepmc   +1 more source